But there are two signals that are new to this class and worth understanding, because they are the ones a prescriber would be watching for
Made without gluten, lactose, or GMOs
Ozempic Use Linked to Adverse Gastrointestinal Events Study Highlight: Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss In October 2023, researchers at the University of British Columbia published findings in the Journal of the American Medical Association (JAMA), which found an increased risk of adverse gastrointestinal events associated with GLP-1 receptor agonists used for weight loss
Orforglipron is safe and generally well tolerated in most individuals
Traditional pay-per-visit models can make ongoing care feel financially out of reach, especially when a program requires consistent follow-up over several months
Consequently, claims of no skin-cancer concern are not scientifically justified